The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...
GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has acquired a majority interest in Aurion Biotech, Inc., ...
A patient with synovial sarcoma, a soft-tissue cancer that usually occurs in the large joints of the arms and legs, is the ...
Doha: Sidra Medicine has announced the successful completion of its first pediatric allogeneic hematopoietic stem cell transplantation (HSCT), ...
Marks a pivotal step toward scalable, accessible, off-the-shelf cell therapies for solid tumoursOslo, Norway, 17 December ...
IMA203CD8 is a second-generation PRAME cell therapy with enhanced pharmacology in ongoing Phase 1a dose escalationManageable ...
A new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond Street Hospital (GOSH), has shown promising results in helping children ...
Lymphedema Treatment Act: A Critical Step for Cancer Survivors, but Unresolved Equity Gaps Persist Patients with advanced melanoma resistant to immune checkpoint or BRAF/MEK inhibitors have treatment ...
Advancements in understanding tumor biology, identifying predictive biomarkers, and developing targeted therapies have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback